Skip to main content Skip to search Skip to main navigation

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

0 reviews

Average rating of 0 out of 5 stars

Leave a review!

Share your experiences with other customers.

Product Information

Your knowledge portal for GDP-compliant pharmaceutical logistics. 

It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain!

The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.

One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.

You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP).

  • Where does GDP begin, where does GMP end? What does GDP-compliant mean?
  • When do I also have to take GMP requirements into account?
  • What permits do I need for certain activities?
  • What requirements do I have to fulfil?
  • What is the current legal basis?
  • How am I covered?
  • What authorizations do I have for my work, e.g. from my employer?
  • Who is responsible — the client or the contractor?
  • And many more

What is the difference to the GMP Compliance Adviser?

GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients.
The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance.

In addition, sample documents are available to help you make immediate progress.

Author

Simone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

Available Subscription Plans: Named User Licence (3-month-subscription), Named User Licence (12-month-subscription), Business Package with 5 Named User Licences (12-month-subscription)

With the GMP:KnowHow Pharma Logistics (GDP), you 

  • have access to all relevant information 24/7. 
  • are always up to date thanks to continuous updating. 
  • download practical, editable templates, including SOPs, job descriptions, Quality Agreements (QAs), and more.
  • save a lot of time searching for applicable regulations. 
  • understand even complex topics through practical examples and infographics.

What you need to use our portals: Technical requirements

Contents of the GMP:KnowHow Pharma Logistics (GDP)

  • In the “Practical Knowledge” section, each GDP chapter is explained and interpreted in a clear and practical way.
  • In the “Regulations” tab, you will find all relevant passages from the various pieces of legislation that have been assigned to the respective GDP chapter. This provides a direct overview of the regulatory requirements relevant to each topic.
  • Quality Agreement for GMP/GDP-compliant Logistics Services 
  • Quality Manual 
  • Standard Operating Procedures (SOPs)
  • Job Descriptions 
  • GDP Questionnaire 
  • Site Master File including Organisational Chart 
  • Best practice – the Peither Logistik GmbH

Updates

GMP:KnowHow Pharma Logistics (GDP) is continuously updated to ensure access to the latest information and practical guidance.

All updates are included for the duration of the subscription.

Newsletter Service: You will automatically receive email notifications about important updates and changes through our GMP Insider newsletter.

Target Group

Professionals involved in the storage and transportation of pharmaceutical products:

  • Logistics companies
  • Logistics and quality departments in pharmaceutical companies
  • Wholesalers

GMP:KnowHow Pharma Logistics (GDP) focuses on content that is essential for pharmaceutical logistics service providers and their clients involved in the handling of medicinal products, active pharmaceutical ingredients (APIs), and medical devices.

Do You Have Questions?

Yannic Matt, Kundenbetreuung und IT-Support beim GMP-Verlag

Talk to our customer advisors

Do you have any questions about our products and services? We are here to help.

Customer Reviews

0 reviews

Average rating of 0 out of 5 stars

Leave a review!

Share your experiences with other customers.

You may Also be Interested in the Following Products

Skip product gallery

Recommendations

GMP:KnowHow Pharma Logistics (GDP) | Free Demo Access

GMP:KnowHow Pharma Logistics (GDP) | Free Demo Access

Your perfect tool for GDP-compliant storage and transportation The demo access is free and absolutely non-binding. It ends automatically after 7 days. How the GMP:KnowHow Pharma Logistics (GDP) supports you: Practical Knowledge Here, the respective GDP chapter is summarized and interpreted in simple terms. In particular, the practical implementation at a logistics service provider is considered in the interpretation. You also receive many editable sample documents. By the way – you can always ask our experts: Ask your specific questions directly form the online portal. Receive personal answers. Regulations All relevant GDP regulations are covered and are always up-to-date. You will find all relevant passages from the various pieces of legislation that have been assigned to the respective GDP chapter. This gives you a direct overview of the underlying regulatory requirements for each topic.

delivery immediately after receipt of payment
€0.00 net excl. VAT
GMP Compliance Adviser | Corporate Licence | 12M

GMP Compliance Adviser | Corporate Licence | 12M

The GMP Compliance Adviser is an online publication that covers all aspects of Good Manufacturing Practice (GMP) in one source.In the GMP Compliance Adviser you’ll find: GMP in Practice This part contains 21 chapters with GMP expert knowledge to base your decisions upon. It provides practical assistance with checklists, templates and SOP examples. It is written by more than 80 authors with hands-on experience directly linked to the industry. The individual chapters describe the different aspects of GMP in clear language. Technical, organizational and procedural aspects are covered.More than 700 checklists, templates and examples of standard operation procedures taken directly out of practice help you in understanding the GMP requirements.GMP RegulationsThese chapters cover the most important GMP regulations from Europe and the United States (CFR and FDA), but also PIC/S, ICH, WHO and many more.  Sample Documents In addition, the GMP Compliance Adviser contains many sample documents and practical examples that you can use.

delivery time appr. 2-5 workdays after receipt of payment
€3,567.00 net excl. VAT

Recommended Articles

EDQM: Revised Guidance on Sister File Applications

EDQM: Revised Guidance on Sister File Applications

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has revised its Guidance on applications for “sister files” (PA/PH/CEP (09) 141). The revision is intended to support consistent application of the procedure and provide greater clarity on the classification and assessment of the corresponding CEP applications.
Read more
Swissmedic Clarifies Requirements for QR Codes on Medicinal Product Packaging

Swissmedic Clarifies Requirements for QR Codes on Medicinal Product Packaging

Swissmedic has revised its guidance document “Mobile technologies” and added two new entries to the related questions and answers. The update follows an increasing number of queries regarding the details and placement of URLs, the positioning of QR codes and their captions.
Read more
EMA: Withdrawal of an Application due to Missing Confirmation of a Manufacturing Site’s GMP Status

EMA: Withdrawal of an Application due to Missing Confirmation of a Manufacturing Site’s GMP Status

EMA reported that Scholar Rock Netherlands withdrew its application for Isembyld after evaluation had progressed through the final round of questions. EMA’s provisional view was that the medicine could not be authorised because the applicant had not provided confirmation that the manufacturing site complied with EU GMP requirements.

Read more
France: ANSM Launches Pilot Project to Extend the Shelf Life of Medicines

France: ANSM Launches Pilot Project to Extend the Shelf Life of Medicines

The French medicines agency ANSM has published an update on its “Longue vie aux médicaments” pilot project aimed at extending the shelf life of medicines. Fourteen pharmaceutical companies responded to the call for applications. The project covers a total of 73 medicines, including commonly used products containing paracetamol, levothyroxine, melatonin or lithium.
Read more
Outsourced Activities in the GDP Environment Part I: Supplier Management

Outsourced Activities in the GDP Environment Part I: Supplier Management

Supplier management is the systematic management of a company´s relationship with its suppliers. It encompasses supplier qualification and customer audits as described in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

Read more
How is First Air Verified and Monitored During Aseptic Process Qualification?

How is First Air Verified and Monitored During Aseptic Process Qualification?

Here's the answer:
Read more
FDA: Draft Guidance on Assessing Container Closure Systems for Drugs and Biologics

FDA: Draft Guidance on Assessing Container Closure Systems for Drugs and Biologics

On 14 August 2026, the US Food and Drug Administration (FDA) announced the publication of a new draft guidance document entitled ‘Container Closure Systems for Human Drugs and Biological Products’.

Read more
FDA: New FDA Commissioner Dr. Heidi Overton

FDA: New FDA Commissioner Dr. Heidi Overton

President Donald Trump has named White House aide Heidi Overton to lead the US Food and Drug Administration (FDA). Overton will fill the position previously held by Marty Makary, who left the agency in May. This announcement was made on Trump's Truth Social account on 19 August. Her nomination is subject to confirmation by the Senate.

Read more
IPEC: Stability Guide for Excipients has been Updated

IPEC: Stability Guide for Excipients has been Updated

The IPEC Stability Guide for Pharmaceutical Excipients has been updated and is now available as version 3 (2026), as announced on the IPEC (International Pharmaceutical Excipients Council) website.

Read more
EU: “Forever Chemicals” in a Conflict of Interests

EU: “Forever Chemicals” in a Conflict of Interests

On 14 July 2026, the European Parliamentary Research Service (EPRS) published a comprehensive briefing on PFAS (per- and polyfluoroalkyl substances), also known as ‘forever chemicals’. The document is intended to serve as a technical basis for MEPs in their upcoming political decisions on PFAS regulation and summarises the current state of scientific knowledge, regulation and procedures.

Read more
Handover of Computerised Systems to the Operating Department

Handover of Computerised Systems to the Operating Department

The GMP-compliant handover of computerised systems to operations is a critical step in the Computer System Validation (CSV) lifecycle. Beyond go-live and hypercare, clearly defined responsibilities, comprehensive documentation and well-trained personnel are essential to maintaining a validated state throughout routine operation.
Read more
How is the Effectiveness of CAPAs Verified?

How is the Effectiveness of CAPAs Verified?

Here's the answer:
Read more
Previous
Next